Growth Metrics

Elevance Health (ELV) Change in Acquisitions & Divestments (2016 - 2025)

Elevance Health (ELV) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $576.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 5.88% to $576.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 12.54% decrease, with the full-year FY2025 number at $1.8 billion, down 12.54% from a year prior.
  • Change in Acquisitions & Divestments was $576.0 million for Q4 2025 at Elevance Health, up from $447.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $7.1 billion in Q2 2023 to a low of -$11.6 billion in Q4 2023.
  • A 5-year average of $1.1 billion and a median of $977.0 million in 2021 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 215.27% in 2022, then tumbled 484.57% in 2023.
  • Elevance Health's Change in Acquisitions & Divestments stood at $956.0 million in 2021, then skyrocketed by 215.27% to $3.0 billion in 2022, then crashed by 484.57% to -$11.6 billion in 2023, then surged by 104.69% to $544.0 million in 2024, then increased by 5.88% to $576.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Change in Acquisitions & Divestments are $576.0 million (Q4 2025), $447.0 million (Q3 2025), and $324.0 million (Q2 2025).